More on IMMP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.40 |
|
|||
| Open | $0.39 | ||||
| 52 Wk High | $0.01 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $0.41 | ||||
| Day Low | $0.38 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 310,718 | ||||
- Form 6-K IMMUTEP Ltd For: Jul 13
- Immutep Limited (IMMP) Reiterated at Market Perform by Citizens on Phase 1 Data
- Form 6-K IMMUTEP Ltd For: Jun 04
- SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP
- Immutep Receives Nasdaq Notice of Bid Price Deficiency
- Immutep Quarterly Activities Report Q3 FY26
- Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
- Form 3 IMMUTEP Ltd For: Mar 18 Filed by: Boyce Elisabeth Amanda
- Immutep gets FDA orphan drug status for cancer treatment
- Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
Entities mentioned with IMMP
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Pre Market Movers | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maxim Group | View Related Stories »
- Pre-Open Losers | View Related Stories »
- Show More...
